Achiko AG (XSWX:ACHI) Equity-to-Asset : -2.94 (As of Jun. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Achiko AG Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Achiko AG's Total Stockholders Equity for the quarter that ended in Jun. 2022 was CHF-6.70 Mil. Achiko AG's Total Assets for the quarter that ended in Jun. 2022 was CHF2.28 Mil.

The historical rank and industry rank for Achiko AG's Equity-to-Asset or its related term are showing as below:

XSWX:ACHI's Equity-to-Asset is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 0.46
* Ranked among companies with meaningful Equity-to-Asset only.

Achiko AG Equity-to-Asset Historical Data

The historical data trend for Achiko AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Equity-to-Asset Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Equity-to-Asset

-0.19

0.19

-2.29

-2.40

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Equity-to-Asset	Get a 7-Day Free Trial			-0.37	-2.29	-2.58	-2.40	-2.94

Competitive Comparison of Achiko AG's Equity-to-Asset

For the Health Information Services subindustry, Achiko AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achiko AG's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Achiko AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Achiko AG's Equity-to-Asset falls into.

Achiko AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Achiko AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Equity to Asset (A: Dec. 2021 )	=	Total Stockholders Equity	/	Total Assets
	=	-4.223	/	1.763
	=	-2.40

Achiko AG's Equity to Asset Ratio for the quarter that ended in Jun. 2022 is calculated as

Equity to Asset (Q: Jun. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	-6.702	/	2.278
	=

Achiko AG (XSWX:ACHI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Achiko AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Achiko AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (XSWX:ACHI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines